Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
|
| gptkbp:ATCCode |
J01CA13
|
| gptkbp:brand |
Ticar
Ticarcillin Disodium |
| gptkbp:CASNumber |
34787-01-4
|
| gptkbp:chemicalFormula |
C15H16N3NaO6S2
|
| gptkbp:combines |
gptkb:clavulanic_acid
|
| gptkbp:developedBy |
1970s
|
| gptkbp:eliminationHalfLife |
1.1 hours
|
| gptkbp:excretion |
renal
|
| https://www.w3.org/2000/01/rdf-schema#label |
ticarcillin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits bacterial cell wall synthesis
|
| gptkbp:molecularWeight |
415.43 g/mol
|
| gptkbp:notEffectiveAgainst |
gptkb:methicillin-resistant_Staphylococcus_aureus_(MRSA)
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
nausea
diarrhea rash allergic reactions thrombophlebitis |
| gptkbp:spectrumOfActivity |
broad-spectrum
|
| gptkbp:usedFor |
bacterial infections
pseudomonas infections |
| gptkbp:bfsParent |
gptkb:clavulanic_acid
|
| gptkbp:bfsLayer |
6
|